While the therapeutic potential of reelin might not be apparent straightaway—after all, glioblastoma cells will have invaded the brain prior to clinical presentation—we feel that, therefore, prior to any potential medical invasion, utilizing part of its peptide sequence might be a valuable contribution to any multi-modular therapy. Here, RELN is linked to glioblastoma.